Johnson & Johnson MedTech has launched the ETHICON 4000 Stapler in the US to enhance surgical outcomes by managing tissue complexities and minimising leaks and bleeding.
The advanced stapler, featuring proprietary 3D Stapling Technology, is designed to improve staple line integrity across various surgical specialities.
The ETHICON 4000 Stapler incorporates a redesigned end effector and streamlined reload options, ensuring consistency from the first to the last staple.
Approved for both open and laparoscopic surgeries, the stapler and its 3D Reloads are also planned for future use with the OTTAVA Robotic Surgical System.
The company will present the ETHICON 4000 System at the American Society for Metabolic and Bariatric Surgery Annual Meeting in Washington, DC, from 15-19 June 2025.
Johnson & Johnson MedTech group chairman Hani Abouhalka said: “We are building on a legacy of innovation and trusted performance in surgical instrumentation to offer new innovations that address some of the most common and costly surgical complications.
“As surgeons work diligently to meet the changing needs of patients, surgical technology must adapt. Johnson & Johnson MedTech is responding by delivering innovation for consistent and reliable experiences across open, minimally invasive, and robotic surgery.”
The ETHICON 4000 Stapler aims to address surgical complications, reducing staple line interventions due to bleeding by 23% compared to traditional 2D staples.
Since 2017, surgical stapling devices have been shown to improve clinical and economic outcomes across various procedures, including bariatric, thoracic, and colorectal surgeries.
The ETHICON 4000 Stapler and 3D Reloads build on the established success, offering enhanced Gripping Surface Technology.
The stapler aims to stabilise the tissue and reduce slippage while delivering staples with offset closure for better compression distribution and staple line integrity.
UCSF Fresno Medical Education Program clinical professor of surgery and Fresno Heart and Surgical Hospital VP and chief medical and quality officer Kelvin Higa said: “The 3D Stapling Technology allows me to more evenly distribute pressure throughout the staple line with more consistency.
UT Health Houston minimally invasive and elective general surgery chief Erik Wilson said: “When I am performing surgery, potential complications related to tissue variability are top of mind.
“Consistency and reliability of performance across open, laparoscopic, and robotic surgery could address a significant unmet need in today’s OR.”
